The Active & Intelligent Packaging Industry Association, AIPIA, is delighted to announce that GlaxoSmithKline (GSK) will be hosting this year’s AIPIA Congress Challenge.
As one of the world’s leading over-the-counter healthcare companies, GSK develops and markets a wide portfolio of trusted brands in Respiratory, Oral and Skin health, Nutrition and Pain relief categories. GSK will be challenging Active & Intelligent Packaging companies to show how disruptive technologies can offer routes to better consumer interaction and engagement at retail shelf and via e-commercechannels.
In addition, the healthcare giant will be asking how Active & Intelligent Packaging can add value, compliance, interactive packaging platforms with artificial intelligence, personalisation, with localised alerts on allergen and pain triggers for instance, all the while maintaining a context of a sustainable environment.
Commenting, Sriman Banerjee, GSK Respiratory R&D packaging director, said that he is “excited to take this innovative stride in the journey to benefit our consumers with modern day connected packaging solutions to do more, feel better and live longer.”
Executive director of AIPIA, Eef de Ferrante, said, “This is a landmark Challenge for the Congress to take it purely into healthcare for the first time. It shows clearly that major innovators such as GSK are ready to embrace Active & Intelligent Packaging and engage with its developers in a highly dynamic way on a number of levels.
The 2018 congress is set to be another groundbreaking event.”
